X-linked adrenoleukodystrophy
Involvement of the pontomedullary corticospinal tracts: a useful finding in the diagnosis of X linked adrenoleukodystrophy
... X-linked adrenoleukodystrophy is an uncom- mon disorder characterized by demyelination in the central nervous system. The underlying de- fect is in lignoceryl-coenzyme A ligase, a per- oxisomal ...
6
Overall intact cognitive function in male X-linked adrenoleukodystrophy adults with normal MRI
... Boys and men with the hereditary peroxisomal disorder X-linked adrenoleukodystrophy (ALD) are at risk of developing inflammatory demyelinating lesions in the brain (‘cerebral ALD’) [1]. Although all ...
8
Management of X linked adrenoleukodystrophy in Morocco: actual situation
... X-linked adrenoleukodystrophy is a rare neurodegen- erative disease, and it is the most common peroxisomal ...an X-Linked trait ...
6
The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis
... in X-linked adrenoleukodystrophy (X-ALD) in relation to the evolutionary conservation across the ABCD1 ...in X-ALD were obtained from the X-ALD database ...
13
X linked Adrenoleukodystrophy: The Role of Contrast enhanced MR Imaging in Predicting Disease Progression
... X-linked adrenoleukodystrophy (ALD) is a rare per- oxisomal disorder that affects the white matter of the CNS, adrenal cortex, and testes ...for X-linked ALD is located in Xq28, the ...
6
A three year old boy with X linked adrenoleukodystrophy and congenital pulmonary adenomatoid malformation: a case report
... Case presentation: A 3-year-old Arabic boy from Yemen presented with discoloration of the mucous membranes and nail beds, which were considered cyanoses due to methemoglobinemia. He also had shortness of breath, fatigue, ...
5
Correlating Quantitative MR Imaging with Histopathology in X Linked Adrenoleukodystrophy
... ABBREVIATIONS: ADC ⫽ apparent diffusion coefficient; Cho ⫽ choline-containing compounds; DTI ⫽ diffusion tensor imaging; EPI ⫽ echo-planar imaging; FA ⫽ fractional anisotropy; FLAIR ⫽ fluid-attenuated inversion recovery; ...
9
Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme
... of X-ALD pa- tients is currently offered it is estimated that between 5 and 18% of new patients present with a spontaneous mutation [13, ...as X-ALD [16, ...
11
Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme.
... York X-ALD screening programme and other implementing sites [16, ...ing X-ALD screening programmes will also be able to address other evidence gaps such as the feasibility and efficacy of monitoring, ...
12
Neurological impairment among heterozygote women for X-linked Adrenoleukodystrophy: a case control study on a clinical, neurophysiological and biochemical characteristics
... With the prominent involvement of pyramidal tracts, X-ALD presenting in symptomatic heterozygotes and as male AMN, can be seen as one form of complicated spastic paraplegia (SPG) [34]. Therapeutic trials in men ...
10
The Genetically Modified Polysialylated Form of Neural Cell Adhesion Molecule Positive Cells for Potential Treatment of X Linked Adrenoleukodystrophy
... cure X-ALD ...bral adrenoleukodystrophy, limitations by HLA-matched donors, a considerable risk of mortality, and a narrow thera- peutic window remain to be ...
7
Childhood Cerebral X Linked Adrenoleukodystrophy: Diffusion Tensor Imaging Measurements for Prediction of Clinical Outcome after Hematopoietic Stem Cell Transplantation
... First, it could relate to stabilization of subtle disease in symptoms.20,21 normal-appearing WM on FLAIR that would have otherwise DTI Parameters in Abnormal WM progressed anteriorly, wh[r] ...
9
Disease progression in women with X-linked adrenoleukodystrophy is slow
... The purpose of this follow-up study in women with ALD was to assess whether EDSS, ALDS and SF-36 can detect progression of spinal cord disease and to model the effect of age and the dura[r] ...
15
X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management
... of X-ALD occurs in adolescence (AdolCALD) or adulthood ...of X-ALD is often delayed; particularly when no family history of X-ALD is present and when clinical symptoms of Addison's disease are ...
14
Modeling and rescue of defective blood–brain barrier function of induced brain microvascular endothelial cells from childhood cerebral adrenoleukodystrophy patients
... X-ALD: X-linked adrenoleukodystrophy; ccALD: childhood cerebral adre- noleukodystrophy; BBB: blood–brain barrier; ROS: reactive oxygen species; WT: wild-type; iPSCs: induced pluripotent stem ...
15
Pericarditis as the Presenting Feature of Adrenoleukodystrophy
... X-linked adrenoleukodystrophy is characterized by elevated levels of very long chain fatty acids in the serum, brain, and adrenal glands that can lead to neurodevelopmental impairment and decreased ...
6
X-linked disorders with cerebellar dysgenesis
... because X-linked cerebellar disorders are frequently associated with mild to severe developmental/cognitive ...deficiency, X-linked adrenoleukodystrophy, X-linked ...
11
Alpha thalassaemia-mental retardation, X linked
... X-linked alpha thalassaemia mental retardation (ATR-X) syndrome in males is associated with profound developmental delay, facial dysmorphism, genital abnormalities and alpha thalassaemia. Female ...
9
RICKETS AND MYOPATHY CURED BY REMOVAL OF A NONOSSIFYING FIBROMA OF BONE
... parathyroid hormone-sensitive component of phosphate transport in X-linked hypophos- phatemia. Arnaud, C., Glonieux, F., and Scriver, C.: Serum parathyroid hormone in X-linked hypophosph[r] ...
10
FGF23 and its role in X-linked hypophosphatemia-related morbidity
... Background: X-linked hypophosphatemia (XLH) is an inherited disease of phosphate metabolism in which inactivating mutations of the Phosphate Regulating Endopeptidase Homolog, X-Linked (PHEX) ...
25